MN•CS•IO System: Cross-Species Study for HBB Function in High-Altitude Hypoxia Adaptation

  • Adv Sci (Weinh). 2026 Sep 28:e78002. doi: 10.1002/advs.78002.
Wenqiao Hui  #  1  2 ,  Lin Mao  #  2 ,  Binggang Li  #  2 ,  Hanyue Kang  #  3 ,  Zhengquan Tang  2 ,  Sheng Chen  1 ,  Hui Yang  4 ,  Yu Qiao  1 ,  Huiqian Ding  2 ,  Yuhuan Wang  4 ,  Min Li  2 ,  Junjie Hu  2 ,  Shoudong Ye  2 ,  Xin Wang  2 ,  Xiaobin Xu  3  5 ,  Yupeng Wang  6 ,  Tana Wuren  4 ,  Qian Ban  2 ,  Baowei Zhang  2
Affiliations
  • 1. Anhui Provincial Key Laboratory of Livestock and Poultry Product Safety, Institute of Animal Husbandry and Veterinary Medicine, Anhui Academy of Agriculture Sciences, Hefei, China.
  • 2. Center for Stem Cell and Translational Medicine, School of Life Sciences and Medical Engineering, Anhui University, Hefei, China.
  • 3. Key Laboratory of Advanced Civil Engineering Materials of Ministry of Education, Key Laboratory of D&A for Metal-Functional Materials, School of Materials Science & Engineering, Tongji University, Shanghai, China.
  • 4. Research Center for High Altitude Medicine, Qinghai University, Xining, China.
  • 5. Center for Micro Nano Systems, School of Information Science and Technology (SIST), Fudan University, Shanghai, China.
  • 6. College of Resources and Environment, Anhui Agricultural University, Hefei, China.
  • # Contributed equally.
Abstract

The genetic basis of high-altitude hypoxia adaptation remains largely elusive, particularly the role of HBB. Here, we developed an integrative mesh-nanorod (MN) cell sorting, chitosan nanoparticle (CS) delivery, and in vivo intraosseous (IO) injection (MN•CS•IO) system to functionally investigate HBB in cross-species high-altitude hypoxia adaptation. Using this MN•CS•IO platform, we transplanted high/low-altitude species HBB-modified lineage-negative (Lin-) cells into murine models, achieving 95.59% transfection efficiency and 8.15% HBB relative expression, and subjected them to simulated and natural Qinghai-Tibet hypoxia conditions. High-altitude HBB recipients exhibited downregulated Rragd expression, activated oxygen transport and hematopoietic lineage pathways, improved behavioral performance, and neuroprotection against hypoxia-induced damage, compared with low-altitude Animals. MN•CS•IO system data demonstrate that HBB determines high-altitude hypoxia adaptation. For validation, we generated bone marrow chimeras using CD45.1 hematopoietic cells with Pika-HBB integrated at the Rosa26 locus. The reconstituted mice exhibited consistent hypoxic behavioral and phenotypic alterations with those observed via the MN•CS•IO system, validating the reliability and stability of HBB-mediated high-altitude hypoxia adaptation. Together, our findings demonstrate that HBB is a key genetic determinant of high-altitude hypoxia adaptation, and also introduce a versatile gene-function validation tool for evolutionary and biomedical research.

Keywords
HBB; Qinghai‐Tibet Plateau animals; gene delivery; high‐altitude; hypoxia adaptation.
Products